🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07557797
Starting soon Not applicable

Gait Retraining for Runners With Patellofemoral Pain

NCT07557797 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Sport University
Phase
Not applicable
Started
2026-05-15
Last updated
2026-04-29

Condition(s) studied

Patellofemoral Pain, PFP

Investigational drug(s) / intervention(s)

Gait retrainingEducation

Gait retraining: The intervention is a wearable device-assisted gait retraining program (home) designed specifically for female runners with patellofemoral pain.

Education: PFP education, load management strategies, symptom-based training modifications, and strengthening exercises

Study summary

Patellofemoral pain (PFP) is a common overuse injury in runners. Increased patellofemoral joint stress (PFJS) is an important biomechanical factor associated with PFP. Gait retraining, especially cadence modification, may reduce PFJS and improve symptoms, but evidence from randomized controlled trials remains limited. This study investigated whether wearable device-assisted gait retraining was more effective than education alone in reducing pain, improving function, and altering running biomechanics in female runners with PFP.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * Female, Age 18-45 years * Unilateral/bilateral anterior knee pain \> 4 weeks * VAS pain ≥ 3/10 during running and ≥ 2 of the following: jumping, squatting, kneeling, stairs, prolonged sitting, or resisted knee extension * Running ≥ 15 km per week * Natural rearfoot striker Exclusion Criteria: * Acute trauma, history of patellar dislocation, meniscal/chondral lesions * Prior knee surgery or injection in past 12 months * Rheumatologic, neurologic, or degenerative disease * Pregnancy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beijing Sport University Beijing China

More Beijing Sport University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07557797 on ClinicalTrials.gov ↗ ← All trials in China